Experts call for better diagnostics as Alzheimer's drug rollout begins

As Taiwan begins administering two newly approved drugs for early-stage Alzheimer's disease, medical experts on Wednesday said more accurate diagnostic tools are needed to identify suitable patients and guide treatment decisions.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)